MedPath

The Effects of a Systematic Pain Assessment Approach on Critically Ill Patients Outcomes in ICU

Not Applicable
Conditions
Pain
Interventions
Other: Systematic pain assessment
Other: Notification of results of assessments
Registration Number
NCT02435589
Lead Sponsor
Cyprus University of Technology
Brief Summary

The purpose of this study is to investigate the effectiveness of a systematic approach to pain assessment in the critically ill patients' outcome The investigators hypothesize that, patients who will undergo systematic pain assessment and they will have their results notified to physicians and nurses, will demonstrate favorable effects on pain intensity, more efficient use of sedatives and analgesics, duration of mechanical ventilation, length of ICU stay, mortality, adverse events and complications, in relation to patients who will receive standard care alone. Moreover it is expected that they will demonstrate altered levels of plasma neuropeptides and biochemical markers in peripheral blood.

Detailed Description

Appropriate pain management depends on the systematic and comprehensive assessment of pain. Inaccurate pain assessment and the resulting inadequate treatment of pain in critically ill adults can have significant physiological and psychological consequences.

The investigators will examine whether a systematic pain assessment approach can improve patients outcomes.

120 ICU patients will be randomized either to control or intervention group. The control group will receive standard care plus pain assessments but nurses and physicians will be blind of these results. The intervention group will receive standard care plus systematic pain assessment and the results will be notified to nurses and physicians.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • 18 years and older
  • All patients with an estimated source of pain or due to immunological process as trauma, surgery, or due to general factors such as endotracheal intubation, interventional catheters
Exclusion Criteria
  • Length of stay in the ICU <24 hours
  • The patient receives neuromuscular blockers,
  • The patient has a disease or condition, such as Guillain-Barre, peripheral neuropathy, which modifies sensory transmission of painful stimuli
  • The patient has a disease or condition which complicates the assessment of pain behavior, such as decerebration or vegetative state, agitation> 3 in the Richmond Agitation sedation Scale (RASS)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control GroupSystematic pain assessmentIntervention. Systematic pain assessments. Assessments of pain will be done by independent assessors but results will not be notified to nurses or physicians
Intervention groupNotification of results of assessmentsIntervention: 1. systematic pain assessment 2. Notification of results of assessments to nurses and physicians. Pain Assessments will be done with the use of 2 different behavioral pain tools by independent assessors and the results of the assessments will be notified to the nurses and physicians and their respond will be observed and documented
Intervention groupSystematic pain assessmentIntervention: 1. systematic pain assessment 2. Notification of results of assessments to nurses and physicians. Pain Assessments will be done with the use of 2 different behavioral pain tools by independent assessors and the results of the assessments will be notified to the nurses and physicians and their respond will be observed and documented
Primary Outcome Measures
NameTimeMethod
a) Level of pain (intensity, incidence of high levels of pain with a numerical pain scale NRS> 6, Behavioral pain scale (BPS) > 5 and Critical pain observation Tool (C-POT) >2morning between 9:00-11: hrs, and afternoon between 4:00-6:00 hrs) for ten continuous days
To investigate the effect of the systematic assessment of pain among patients groups - control and intervention as to:The total dose, frequency of administration and the type of analgesics and sedatives receivedevery 24 hrs for ten continuous days
Secondary Outcome Measures
NameTimeMethod
Effect of the systematic evaluation of pain among patients groups - control and intervention as to:The degree of sedation/agitationmorning between 9:00-11: hrs, and afternoon between 4:00-6:00 hrs) for ten continuous days
Effect of the systematic evaluation of pain among patients groups - control and intervention as to:The levels of biochemical marker, cortisol, in the serummorning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample)
Effect of the systematic evaluation of pain among patients groups - control and intervention as to: The levels of neuropeptide Ymorning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample)
Effect of the systematic evaluation of pain among patients groups - control and intervention as to: The levels of neuropeptide , substance P in the serummorning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample)
Effect of the systematic evaluation of pain among patients groups - control and intervention as to:The levels of biochemical marker corticotrophin hormone -ACTH in the serummorning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample)
Effect of the systematic evaluation of pain among patients groups - control and intervention as to: The levels of biochemical marker, b-endorphin in the serummorning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample)
To investigate the effect of the systematic assessment of pain among patients groups - control and intervention as to the occurrence of adverse eventsevery 24 hrs for ten continuous days
To investigate the effect of the systematic assessment of pain among patients groups - control and intervention as to duration of mechanical ventilationDay and time of initiation of mechanical ventilation till the day and time of end of mechanical ventilation, up to six months.
To investigate the effect of the systematic assessment of pain among patients groups - control and intervention as to length of stay in the ICUFrom the day of admission to ICU till the day of discharge from ICU, up to six months

Trial Locations

Locations (1)

Nicosia General Hospital

🇨🇾

Nicosia, Cyprus

© Copyright 2025. All Rights Reserved by MedPath